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Benchmarking neonatal
anthropometric charts published
in the last decade
In a commentary published in this journal,1
we defined the characteristics that a reliable
neonatal anthropometric chart should pos-
sess to be of both clinical and epidemiologi-
cal use. With the aim of assessing to what
extent the neonatal charts published in the
last decade present such characteristics, we
examined the relevant literature published
from January 1998 to September 2008.
The search strategy in Medline used the
following text words and MeSH terms:
[(newborn* OR neonatal*) AND (growth
charts OR growth curves OR anthropo-
metric charts OR anthropometric curves
OR intrauterine growth charts OR intrau-
terine growth curves) AND (birthweight OR
birth head circumference OR birth length)
AND (centile* OR percentile* OR gesta-
tional age OR LMP) AND (singleton OR
standard* OR reference*) NOT longitudi-
nal]. The PubMed ‘‘related articles’’ function
was used to search for other relevant papers
not retrieved in the initial search. No
language restriction was applied. A total of
43 sets of neonatal charts (a set consisting of
all the charts referred to the same target
population) was identified. Table 1 sum-
marises the results of our appraisal.
General agreement seems to have been
achieved over the debated question whether
a neonatal chart should be a reference or a
standard, as the large majority (80%) of
charts included in this analysis are a
reference (which describes ‘‘how growth
actually is’’ in a given population), with
the only exclusion being stillbirths and
major congenital anomalies, rather than a
standard (which indicates ‘‘how growth
should be’’), with the exclusion of all
neonates exposed to any known risk factor
for intrauterine growth.
About two-thirds of the charts are specific
for gender and single pregnancy, whereas
only a few of them are specific for parity
(primiparae/multiparae), which is a mater-
nal constraint known to affect fetal growth.
In 10 cases, the minimum gestational age
considered in the charts is 30 weeks or
higher, so these charts are unsuitable for
the assessment of many preterm neonates.
Reliable neonatal charts require reliable
estimates of gestational age. Unfortunately,
in 80% of the studies under examination,
gestational age is derived from the reported
last menstrual period and not from the
ultrasound assessment. In only four papers
are both estimates considered.2–5
Reliable neonatal charts require reliable
anthropometric measures. Regrettably, only
30% of the surveys meet these requirements.
Finally, only three charts were traced
using the LMS model.7 In the absence of a
model that takes into account the changes in
the skewness of distribution of the anthro-
pometric traits with gestational age, the
observed values cannot be transformed into
z scores. These are particularly useful when
the sizes of neonates of different gestational
age are to be compared.
Because of the large methodological het-
erogeneity underlying the neonatal anthro-
pometric charts examined here, we are
unable to assert whether or not the observed
anthropometric differences reflect actual
differences among populations. This fact
constitutes a limitation in the use of these
charts mainly for epidemiological aims. A
deeper consideration of methodological
aspects may improve the quality and useful-
ness of neonatal charts.
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Giving vancomycin as a
continuous infusion
The recent paper advocating ‘‘a new dosage
schedule’’ for giving vancomycin in early
infancy1 confirms what others have long said
is usually the most appropriate total daily
dose for babies of less than 34 weeks’ gesta-
tion who are more than a week old, and
focuses on the time-dependent rather than
the concentration-dependent mode of vanco-
mycin killing. Continuous infusion may
prevent the risks of high peaks and low
troughs seen with intermittent dosage.
However, we disagree with the suggestion
that a first loading dose is not necessary. The
earlier paper that recommended this same
strategy 10 years ago2 correctly said,
‘‘Vancomycin half-life is usually between 3
and 10 h in neonates. The time to reach
steady state, which is 4 to 5 times the half-life,
might thus be expected to be around 48 h in
this specific population. Such a time to reach
early bactericidal efficacy appeared too long in
cases of septicaemia. For this reason, we
decided to inject a 7 mg kg21 loading dose’’.
The one trial to look at the relative merits
of intermittent and continuous infusion,
which found no evidence that continuous
infusions were better than intermittent
infusions in adults,3 also used a loading dose.
The reference used to justify the assertion
that a loading dose is not necessary was data
presented by poster stating that therapeutic
levels were reached within 12 h in much
older children,4 but this overlooks the fact
that the half-life is much shorter in 5–10-
year-old children than it is in the first few
weeks of life and, indeed, also rather shorter
than it is adult life.
Failure to give a loading dose where there
is clear evidence of septicaemia will leave
any young baby dangerously under-treated
for many hours. There are reasons for
thinking that a continuous infusion may
be a useful option when treating meningitis,
as the discussion of these issues in the
Neonatal Formulary web site argues,5 but a
loading dose is required.
Table 1 Adherence to the characteristics
suggested for a reliable neonatal
anthropometric chart
Characteristic N (%)
Pre-planned multicentre ad hoc study 4 (9)
Descriptive reference 36 (84)
Mono-ethnic population 13 (30)
Charts specific for gender 31 (72)
Charts specific for single or multiple pregnancy 33 (77)
Charts specific for parity 4 (9)
Reliable gestational age assessment 4 (9)
Reliable measuring techniques and instruments 13 (30)
Range of gestational age from 42 to 24 weeks
or less
21 (49)
HRY6 or LMS method7 used to trace neonatal
charts
4 (9)
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